A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

Purpose

This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Condition

  • Biliary Cirrhosis, Primary

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients (age 18 or older) being treated or managed for PBC

Exclusion Criteria

  • Inability to provide written informed consent
  • Simultaneous enrollment in another prospective registry or clinical trial or study where PBC treatment outcomes are reported, except where approved or conducted as an adjunct project of TARGET-PBC

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

More Details

NCT ID
NCT02932449
Status
Active, not recruiting
Sponsor
Target PharmaSolutions, Inc.

Study Contact